-
Full Article (HTML) (117) -
Full Article (PDF) (45) -
Send to Friends (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4567)
All Articles published online
|
Publishing Process of This Article
|
Sep 21, 2017 (publication date) through May 19, 2022
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lovecek M, Skalicky P, Chudacek J, Szkorupa M, Svebisova H, Lemstrova R, Ehrmann J, Melichar B, Yogeswara T, Klos D, Vrba R, Havlik R, Mohelnikova-Duchonova B. Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature. World J Gastroenterol 2017; 23(35): 6420-6428 [PMID: 29085191 DOI: 10.3748/wjg.v23.i35.6420] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v23/i35/6420.htm |
| Number | Citing Articles |
| 1 |
Taro Mashiko, Akira Nakano, Yoshihito Masuoka, Seiichiro Yamamoto, Soji Ozawa, Toshio Nakagohri. Significance of pulmonary resection in patients with metachronous pulmonary metastasis from pancreatic ductal adenocarcinoma: a retrospective cohort study. BMC Surgery 2021; 21(1) doi: 10.1186/s12893-021-01236-w
|
| 2 |
Kun Wang, Zhiqiang Hao, Xibo Fu, Wenxin Li, Ao Jiao, Xiangdong Hua. Involvement of elevated ASF1B in the poor prognosis and tumorigenesis in pancreatic cancer. Molecular and Cellular Biochemistry 2022; doi: 10.1007/s11010-022-04404-5
|
| 3 |
Tatsuma Sakaguchi, Roberto Valente, Kimitaka Tanaka, Sohei Satoi, Marco Del Chiaro. Surgical treatment of metastatic pancreatic ductal adenocarcinoma: A review of current literature. Pancreatology 2019; 19(5): 672 doi: 10.1016/j.pan.2019.05.466
|
| 4 |
Koki Hayashi, Yoshihiro Ono, Manabu Takamatsu, Atsushi Oba, Hiromichi Ito, Takafumi Sato, Yosuke Inoue, Akio Saiura, Yu Takahashi. Prediction of Recurrence Pattern of Pancreatic Cancer Post-Pancreatic Surgery Using Histology-Based Supervised Machine Learning Algorithms: A Single-Center Retrospective Study. Annals of Surgical Oncology 2022; doi: 10.1245/s10434-022-11471-x
|
| 5 |
Sami A. Safi, Alexander Rehders, Lena Haeberle, Stephen Fung, Nadja Lehwald, Irene Esposito, Farid Ziayee, Andreas Krieg, Wolfram T. Knoefel, Georg Fluegen. Para-aortic lymph nodes and ductal adenocarcinoma of the pancreas: Distant neighbors?. Surgery 2021; 170(6): 1807 doi: 10.1016/j.surg.2021.06.045
|
| 6 |
Hiroshi Kurahara, Kosei Maemura, Yuko Mataki, Kiyonori Tanoue, Satoshi Iino, Yota Kawasaki, Tetsuya Idichi, Takaaki Arigami, Shinichiro Mori, Yoshiaki Shinden, Michiyo Higashi, Shinichi Ueno, Hiroyuki Shinchi, Shoji Natsugoe. Lung recurrence and its therapeutic strategy in patients with pancreatic cancer. Pancreatology 2020; 20(1): 89 doi: 10.1016/j.pan.2019.11.015
|
| 7 |
Ryota Matsuki, Masanori Sugiyama, Hidefumi Takei, Haruhiko Kondo, Masachika Fujiwara, Junji Shibahara, Junji Furuse. Long-term survival with repeat resection for lung oligometastasis from pancreatic ductal adenocarcinoma: a case report. Surgical Case Reports 2018; 4(1) doi: 10.1186/s40792-018-0435-2
|
| 8 |
E. Martin-Perez, J. E. Domínguez-Muñoz, F. Botella-Romero, L. Cerezo, F. Matute Teresa, T. Serrano, R. Vera. Multidisciplinary consensus statement on the clinical management of patients with pancreatic cancer. Clinical and Translational Oncology 2020; 22(11): 1963 doi: 10.1007/s12094-020-02350-6
|
| 9 |
Jennifer A. Yonkus, Roberto Alva-Ruiz, Amro M. Abdelrahman, Jennifer L. Leiting, Amber R. Schneider, Travis E. Grotz, Sean P. Cleary, Rory L. Smoot, David M. Nagorney, Michael L. Kendrick, Benjamin R. Kipp, Mark J. Truty. Molecular Peritoneal Staging for Pancreatic Ductal Adenocarcinoma Using Mutant KRAS Droplet-Digital Polymerase Chain Reaction: Results of a Prospective Clinical Trial. Journal of the American College of Surgeons 2021; 233(1): 73 doi: 10.1016/j.jamcollsurg.2021.05.009
|
| 10 |
Yuki Homma, Itaru Endo, Ryusei Matsuyama, Masayuki Sho, Shugo Mizuno, Yasuji Seyama, Satoshi Hirano, Takashi Aono, Chie Kitami, Yoshifumi Morita, Yutaka Takeda, Kazuhiro Yoshida, Masaji Tani, Takashi Kaiho, Yuzo Yamamoto, Hideki Aoki, Masao Ogawa, Takefumi Niguma, Yuko Mataki, Hiroshi Kawasaki, Hideo Baba, Hiroshi Yokomizo, Toshiki Rikiyama, Hiroki Yamaue, Masakazu Yamamoto. Outcomes of lung metastasis from pancreatic cancer: A nationwide multicenter analysis. Journal of Hepato-Biliary-Pancreatic Sciences 2022; doi: 10.1002/jhbp.1127
|
| 11 |
Vincent P. Groot, Lois A. Daamen, Jin He, Christopher L. Wolfgang, I. Quintus Molenaar. Textbook of Pancreatic Cancer. 2021; : 1153 doi: 10.1007/978-3-030-53786-9_74
|
| 12 |
Carole Vitellius, Océane Griveaux, Benjamin Morvant, Estelle Pedrono, Aurélien Venara, Olivier Ingster, Nathalie Baize, Eloise Dincuff, Marie-Christine Rousselet, Philippe Guardiola, François-Xavier Caroli-Bosc. Impact of Driver Mutations on the Evolution of Isolated Metachronous Lung Metastasis of Pancreatic Ductal adenocarcinoma. Molecular Diagnosis & Therapy 2020; 24(4): 443 doi: 10.1007/s40291-020-00472-9
|
| 13 |
Xiaodong Xu, Yan Yu, Ke Zong, Pengwei Lv, Yuantin Gu. Up-regulation of IGF2BP2 by multiple mechanisms in pancreatic cancer promotes cancer proliferation by activating the PI3K/Akt signaling pathway. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1470-y
|
| 14 |
Yixuan Ma, Sina Sender, Anett Sekora, Weibo Kong, Peter Bauer, Najim Ameziane, Susann Krake, Mandy Radefeldt, Ruslan Al-Ali, Frank Ulrich Weiss, Markus M. Lerch, Alisha Parveen, Dietmar Zechner, Christian Junghanss, Hugo Murua Escobar. Inhibitory Response to CK II Inhibitor Silmitasertib and CDKs Inhibitor Dinaciclib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines. International Journal of Molecular Sciences 2022; 23(8): 4409 doi: 10.3390/ijms23084409
|
| 15 |
S. A. Safi, N. Lehwald-Tywuschik, A. Rehders, G. Fluegen, L. Haeberle, V. Keitel, W. T. Knoefel. Site of relapse of ductal adenocarcinoma of the pancreas affects survival after multimodal therapy. BMC Surgery 2021; 21(1) doi: 10.1186/s12893-021-01082-w
|
| 16 |
Vincent P. Groot, Alex B. Blair, Georgios Gemenetzis, Ding Ding, Richard A. Burkhart, A. Floortje van Oosten, I. Quintus Molenaar, John L. Cameron, Matthew J. Weiss, Stephen C. Yang, Christopher L. Wolfgang, Jin He. Isolated pulmonary recurrence after resection of pancreatic cancer: the effect of patient factors and treatment modalities on survival. HPB 2019; 21(8): 998 doi: 10.1016/j.hpb.2018.12.002
|
| 17 |
Yixuan Ma, Sina Sender, Anett Sekora, Weibo Kong, Peter Bauer, Najim Ameziane, Ruslan Al-Ali, Susann Krake, Mandy Radefeldt, Frank Ulrich Weiss, Markus M. Lerch, Alisha Parveen, Dietmar Zechner, Christian Junghanss, Hugo Murua Escobar. The Inhibitory Response to PI3K/AKT Pathway Inhibitors MK-2206 and Buparlisib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines. International Journal of Molecular Sciences 2022; 23(8): 4295 doi: 10.3390/ijms23084295
|
| 18 |
Lung Metastases in Patients with Stage IV Pancreatic Cancer: Prevalence, Risk Factors, and Survival Impact. Journal of Clinical Medicine 2019; 8(9): 1402 doi: 10.3390/jcm8091402
|
| 19 |
Viktor Hlavac, Beatrice Mohelnikova-Duchonova, Martin Lovecek, Jiri Ehrmann, Veronika Brynychova, Katerina Kolarova, Pavel Soucek. Targeted Sequencing of Pancreatic Adenocarcinomas from Patients with Metachronous Pulmonary Metastases. Genes 2020; 11(12): 1391 doi: 10.3390/genes11121391
|
| 20 |
Masafumi Imamura, Minoru Nagayama, Daisuke Kyuno, Shigenori Ota, Takeshi Murakami, Akina Kimura, Hiroshi Yamaguchi, Toru Kato, Yasutoshi Kimura, Ichiro Takemasa. Perioperative Predictors of Early Recurrence for Resectable and Borderline-Resectable Pancreatic Cancer. Cancers 2021; 13(10): 2285 doi: 10.3390/cancers13102285
|
| 21 |
Thilo Hackert, Markus W. Büchler. Response to the Comment on “Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer”. Annals of Surgery 2021; 274(6): e899 doi: 10.1097/SLA.0000000000004872
|
| 22 |
Tomas Zemanek, Bohuslav Melichar, Martin Lovecek, Pavel Soucek, Beatrice Mohelnikova-Duchonova. Biomarkers and pathways of chemoresistance and chemosensitivity for personalized treatment of pancreatic adenocarcinoma. Pharmacogenomics 2019; 20(2): 113 doi: 10.2217/pgs-2018-0073
|
| 23 |
M Tanaka, A L Mihaljevic, P Probst, M Heckler, U Klaiber, U Heger, M W Büchler, T Hackert. Meta-analysis of recurrence pattern after resection for pancreatic cancer. British Journal of Surgery 2019; 106(12): 1590 doi: 10.1002/bjs.11295
|
| 24 |
Hiroyuki Otsuka, Kenichiro Uemura, Naru Kondo, Tatsuaki Sumiyoshi, Naoya Nakagawa, Kenjiro Okada, Shingo Seo, Yoshiaki Murakami, Shinya Takahashi. Clinical characteristics of initial recurrence in lung after surgical resection for pancreatic ductal adenocarcinoma. Pancreatology 2020; 20(7): 1472 doi: 10.1016/j.pan.2020.08.019
|
| 25 |
Yu Asakura, Hirochika Toyama, Jun Ishida, Sadaki Asari, Sachio Terai, Sachiyo Shirakawa, Hironori Yamashita, Takashi Shimizu, Yuta Ogura, Ippei Matsumoto, Hidetoshi Gon, Daisuke Tsugawa, Shohei Komatsu, Kaori Kuramitsu, Hiroaki Yanagimoto, Masahiro Kido, Tetsuo Ajiki, Takumi Fukumoto. Clinicopathological variables and risk factors for lung recurrence after resection of pancreatic ductal adenocarcinoma. Asian Journal of Surgery 2022; doi: 10.1016/j.asjsur.2022.03.043
|
| 26 |
Yufu Wang, Tianyi Fang, Lining Huang, Hao Wang, Lei Zhang, Zhidong Wang, Yunfu Cui. Neutrophils infiltrating pancreatic ductal adenocarcinoma indicate higher malignancy and worse prognosis. Biochemical and Biophysical Research Communications 2018; 501(1): 313 doi: 10.1016/j.bbrc.2018.05.024
|